Effect of prostaglandin E2 on phospholipase D activity in osteoblast-like MC3T3-E1 cells

J Bone Miner Res. 1995 Aug;10(8):1185-90. doi: 10.1002/jbmr.5650100807.

Abstract

Recent evidence indicates that phosphatidylcholine breakdown by phospholipase D (PLD) is an important cellular control mechanism. We investigated the signaling pathway participating in prostaglandin E2 (PGE2)-induced PLD activation in osteoblast-like MC3T3-E1 cells. PGE2 stimulated PLD activity, as measured by choline generated from phosphatidylcholine, just after the stimulation. The reaction reached a plateau 15 minutes later. PGE2 stimulated PLD activity in a dose-related manner and also increased inositol phosphate (IP) formation. However, the EC50 value for PGE2-induced IP formation is lower than that for PLD activation. 12-O-Tetradecanoylphorbol-13-acetate (TPA), a protein kinase C (PKC) activator, stimulated PLD activity, and a combination of PGE2 and TPA potentiated it in an additive manner. Although NaF, a heterotrimeric GTP-binding protein activator, significantly stimulated PLD activity, this effect was not augmented by combination with PGE2. PGE2-induced PLD activity was markedly suppressed by either chelating extracellular Ca2+ by EGTA or pertussis toxin. These findings suggest that osteoblasts might have at least two PLD activation mechanisms which involve PKC-dependent or -independent pathways. However, present results indicate that PKC is unlikely to be essential to PGE2-induced PLD activation. On the contrary, pertussis toxin-sensitive GTP-binding protein and extracellular Ca2+ might play important roles in the pathway of PGE2-induced PLD activation.

MeSH terms

  • 3T3 Cells / cytology
  • 3T3 Cells / drug effects
  • 3T3 Cells / enzymology
  • Animals
  • Chelating Agents / pharmacology
  • Choline / metabolism*
  • Dinoprostone / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Enzyme Activation / drug effects
  • GTP-Binding Proteins / metabolism
  • Inositol Phosphates / biosynthesis
  • Mice
  • Osteoblasts / cytology
  • Osteoblasts / drug effects*
  • Osteoblasts / enzymology
  • Phosphatidylcholines / metabolism
  • Phospholipase D / metabolism*
  • Sodium Fluoride / pharmacology
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Chelating Agents
  • Inositol Phosphates
  • Phosphatidylcholines
  • Sodium Fluoride
  • Phospholipase D
  • GTP-Binding Proteins
  • Dinoprostone
  • Choline
  • Tetradecanoylphorbol Acetate